DK0938304T3 - Isovaleramid til behandlingen af kramper, epilepsi, hovedpine og spasticitet - Google Patents

Isovaleramid til behandlingen af kramper, epilepsi, hovedpine og spasticitet

Info

Publication number
DK0938304T3
DK0938304T3 DK97941381T DK97941381T DK0938304T3 DK 0938304 T3 DK0938304 T3 DK 0938304T3 DK 97941381 T DK97941381 T DK 97941381T DK 97941381 T DK97941381 T DK 97941381T DK 0938304 T3 DK0938304 T3 DK 0938304T3
Authority
DK
Denmark
Prior art keywords
treatment
isovaleramide
spasticity
seizures
epilepsy
Prior art date
Application number
DK97941381T
Other languages
English (en)
Inventor
Manuel F Balandrin
Linda D Artman
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Application granted granted Critical
Publication of DK0938304T3 publication Critical patent/DK0938304T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Psychology (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK97941381T 1996-08-30 1997-08-29 Isovaleramid til behandlingen af kramper, epilepsi, hovedpine og spasticitet DK0938304T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2505096P 1996-08-30 1996-08-30
PCT/US1997/015272 WO1998008498A1 (en) 1996-08-30 1997-08-29 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants

Publications (1)

Publication Number Publication Date
DK0938304T3 true DK0938304T3 (da) 2005-03-14

Family

ID=21823778

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941381T DK0938304T3 (da) 1996-08-30 1997-08-29 Isovaleramid til behandlingen af kramper, epilepsi, hovedpine og spasticitet

Country Status (16)

Country Link
EP (1) EP0938304B1 (da)
JP (1) JP2000504035A (da)
KR (1) KR100594400B1 (da)
CN (2) CN1531924A (da)
AT (1) ATE284683T1 (da)
AU (1) AU728765B2 (da)
BR (1) BR9713188A (da)
CA (1) CA2264577A1 (da)
DE (1) DE69731968T2 (da)
DK (1) DK0938304T3 (da)
ES (1) ES2235251T3 (da)
HK (1) HK1023725A1 (da)
IL (1) IL128724A (da)
PT (1) PT938304E (da)
RU (1) RU2232016C2 (da)
WO (1) WO1998008498A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589994B1 (en) 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
CA2321737A1 (en) * 1998-03-04 1999-09-10 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
EP1576962A1 (en) * 1998-03-04 2005-09-21 Nps Pharmaceuticals, Inc. Composition comprising isovaleramide and ibuprofen
AU2003204485B2 (en) * 1998-03-04 2006-06-08 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
US6383527B1 (en) * 1999-03-04 2002-05-07 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
US6346283B1 (en) * 1999-03-26 2002-02-12 Ancile Pharmaceuticals Use of valeriana for the treatment of restless leg syndrome and related disorders
EP1225888A2 (en) * 1999-10-19 2002-07-31 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating cns-mediated disorders
US7235258B1 (en) 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
CA2418455A1 (en) * 2000-08-17 2002-02-21 Teva Pharmaceutical Industries, Ltd. Valproic acid derivatives for the treatment of pain
EP1385520A4 (en) * 2001-02-08 2007-03-21 Nps Pharma Inc METHODS AND COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRICAL DISEASES AND FOR THE IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT THEREOF
WO2003063605A1 (en) * 2002-02-01 2003-08-07 Eugene Science Inc. Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease
US20060025477A1 (en) * 2004-07-22 2006-02-02 Artman Linda D Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
RU2460534C1 (ru) * 2011-04-15 2012-09-10 Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) Способ получения средства, обладающего анксиолитической активностью
CN103565959B (zh) * 2013-11-06 2015-04-08 李传平 一种治疗精神***症的汤剂
CN103961341B (zh) * 2014-05-30 2015-12-02 杨献华 一种治疗偏头痛的药物组合物及其应用
EP3423433A4 (en) * 2016-02-29 2019-12-25 Bio-Pharm Solutions Co., Ltd. SULFAMATE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
KR102333460B1 (ko) * 2016-11-15 2021-12-15 경희대학교 산학협력단 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
DE2230626B2 (de) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Baldrianpräparat
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent

Also Published As

Publication number Publication date
RU2232016C2 (ru) 2004-07-10
IL128724A0 (en) 2000-01-31
EP0938304A1 (en) 1999-09-01
DE69731968T2 (de) 2005-12-22
CA2264577A1 (en) 1998-03-05
DE69731968D1 (de) 2005-01-20
CN1152677C (zh) 2004-06-09
CN1235541A (zh) 1999-11-17
PT938304E (pt) 2005-04-29
HK1023725A1 (en) 2000-09-22
IL128724A (en) 2003-05-29
AU728765B2 (en) 2001-01-18
WO1998008498A1 (en) 1998-03-05
ATE284683T1 (de) 2005-01-15
BR9713188A (pt) 1999-11-03
EP0938304B1 (en) 2004-12-15
KR20000038194A (ko) 2000-07-05
CN1531924A (zh) 2004-09-29
AU4330297A (en) 1998-03-19
ES2235251T3 (es) 2005-07-01
KR100594400B1 (ko) 2006-07-03
JP2000504035A (ja) 2000-04-04

Similar Documents

Publication Publication Date Title
DK0938304T3 (da) Isovaleramid til behandlingen af kramper, epilepsi, hovedpine og spasticitet
WO2000051586A3 (en) Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound
UA39172C2 (uk) Похідні 2-(2,6-дигалофеніламіно) фенілоцтової кислоти і спосіб їх одержання
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
HUT68689A (en) Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors, pharmaceutical compositions containing them, process for producing them and the compositions
IT1304152B1 (it) Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
BG105109A (en) Cell adhesion-inhibiting anti-inflammatory compounds
CA2265766A1 (en) Rapidly disintegrating pellets
ATE229533T1 (de) Nitrat-salze als arzneimittel
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
YU52999A (sh) Kombinacija analgetika
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
WO1999044623A8 (en) Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
PT1057826E (pt) Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
MX9605196A (es) Halometilamidas como inhibidores de la proteasa il-1b.
EP0971696A4 (en) THIMEROSAL-FREE PRESERVATIVE FOR VACCINES
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
BG100248A (en) Squalene synthetase inhibitors
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
GR3033430T3 (en) N-protected/n-substituted-beta-amino hydroxy sulfonates
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
IL129786A0 (en) Method of identifying pharmaceuticals from plant extracts